*/
In an era where the surge of artificial intelligence (AI) captures global attention, an equally important but less discussed advancement is making waves – the intersection of neurotechnology and law. This pivotal juncture in human innovation has prompted the establishment of the Institute of Neurotechnology & Law, spearheaded by Harry Lambert, a barrister with a unique blend of expertise in product liability, privacy, and medical law.
In recent years neurotechnology has made great strides, and we now live in a world where brain to brain communication, memory scanning and transcription of thoughts to text (to name but a few) are all possible. As neurotechnology swiftly evolves, its integration into everyday life will have profound implications on privacy, ethics and personal autonomy. Suddenly we need to protect a whole new raft of rights that we never imagined needed protection; what the ethicist Rafael Yuste has called ‘neurorights’.
The foundation of the Institute comes at a critical time. It is no exaggeration to say that recent advances in neurotechnology mark a crucial moment; it is imperative that we engage in balanced and informed debates about neurorights.
The Institute of Neurotechnology & Law aims to ensure that as these technologies develop, they do so in a manner that aligns with the best interests of humanity. The core mission is to foster discussions that will guide the responsible development of neurotechnological innovations. By bringing together legal experts, technologists, bioethicists and policymakers, the Institute seeks to build a robust framework for ethical governance and legislation in this dynamic arena.
It’s common to hear debates surrounding AI, but the fascinating topic of neurotechnology and its legal implications remains largely in the shadows. The Institute of Neurotechnology and Law is set to change that, ensuring that this area receives the attention and scrutiny it deserves. Find out more at www.neurotechlaw.com
In an era where the surge of artificial intelligence (AI) captures global attention, an equally important but less discussed advancement is making waves – the intersection of neurotechnology and law. This pivotal juncture in human innovation has prompted the establishment of the Institute of Neurotechnology & Law, spearheaded by Harry Lambert, a barrister with a unique blend of expertise in product liability, privacy, and medical law.
In recent years neurotechnology has made great strides, and we now live in a world where brain to brain communication, memory scanning and transcription of thoughts to text (to name but a few) are all possible. As neurotechnology swiftly evolves, its integration into everyday life will have profound implications on privacy, ethics and personal autonomy. Suddenly we need to protect a whole new raft of rights that we never imagined needed protection; what the ethicist Rafael Yuste has called ‘neurorights’.
The foundation of the Institute comes at a critical time. It is no exaggeration to say that recent advances in neurotechnology mark a crucial moment; it is imperative that we engage in balanced and informed debates about neurorights.
The Institute of Neurotechnology & Law aims to ensure that as these technologies develop, they do so in a manner that aligns with the best interests of humanity. The core mission is to foster discussions that will guide the responsible development of neurotechnological innovations. By bringing together legal experts, technologists, bioethicists and policymakers, the Institute seeks to build a robust framework for ethical governance and legislation in this dynamic arena.
It’s common to hear debates surrounding AI, but the fascinating topic of neurotechnology and its legal implications remains largely in the shadows. The Institute of Neurotechnology and Law is set to change that, ensuring that this area receives the attention and scrutiny it deserves. Find out more at www.neurotechlaw.com
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
In an era of patient-centred care and growing concern over misconduct in medical settings, why do women still lack the right to choose women consultants for examination and treatment? Charles Davey investigates
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC
